Skip to content

Clinical trials

Observational Hematologic Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Observational Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20161
20191
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swedish Orphan Biovitrum2
Bayer1
BioMarin Pharmaceutical1
National Center for Research Resources (NCRR)1
QIAGEN Gaithersburg, Inc1
Spur Therapeutics1
University Hospitals of North Midlands NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases8
Blood Coagulation Disorders5
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Hemorrhagic Disorders3
Blood Coagulation Disorders, Inherited2
Hemophilia A2
Hemophilia B2
COVID-191
Hemostatic Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.